Skip to content
The third anniversary of the COVID-19 pandemic on March 11 may feel to some like a relief as we transition into a post-COVID era. […]
As the COVID pandemic turns 3, are we ready for the next one? Read More »
“You know,” Karyne Jones laughs, “I am about the same age as many of the people I work with, so the older I get,
NCBA understands that, in Black America, health care is holistic Read More »
For 17 years, BlackDoctor.org (BDO) has been the go-to place for education on public health in the Black community. As CEO Reggie Ware explains,
BDO understands communication is key for Black health Read More »
2023 is shaping up to be the year of RSV—in a good way. RSV (a.k.a. respiratory syncytial virus) has long been a challenge for
Pediatrics might finally have a long-awaited RSV shot Read More »
Already, 2023 is looking like a dynamic year for biotech on the state level as state legislatures nationwide get ready to tackle a few
4 things for biotech to watch in the 2023 state legislatures Read More »
The number of new pain drugs in the development pipeline has slowed to a trickle and investment in addiction drugs is low, challenges addressed
‘All hands on deck’ needed to address U.S. pain and addiction innovation Read More »
“I think we’re in a very exciting time in healthcare and biotech,” said Steven Ladd, Director of Business Development and Acquisitions at AbbVie. “It’s
China-U.S. biotech ventures are where collaboration meets competition Read More »
“It’s exciting times,” said Kathy Fernando, Senior Vice President and Global Head of the Partner of Choice Organization at Pfizer Inc. Speaking about the
Pfizer Ignite’s new model is turning heads and sharing the wealth Read More »
From the colorful glass and plastic bottles that populate medicine cabinets to the ingredients used in common and high-end products, the beauty industry’s output
Biotech can clean up your beauty cabinet for the new year Read More »
At 30-years old, the 340B program is buckling under its own weight and overdue for reform. With legal action, including a Supreme Court ruling,
The 30-year-old 340B drug discount program is due for reform Read More »
